C
C4 Therapeutics, Inc.
CCCC · NASDAQ · Healthcare · 469M
Price · close
$4.00
-0.74% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.3×
Enterprise value / EBITDAEV/EBITDA
-3.1×
Free cash flow yieldFCF yield
-29.9%
Return on equityROE
-40.9%
Operating margin
-290.7%
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.